Related content

Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma

By Tsutsumi Y.  

Annals of Hematology, Vol. 83, Iss. 1, 2004-01 ,pp. : 58-60

Springer Publishing Company

Access to resources Recommend Favorite

High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin’s lymphoma

By Chen Ming-Huang  

Annals of Hematology, Vol. 87, Iss. 6, 2008-06 ,pp. : 475-480

Springer Publishing Company

Access to resources Recommend Favorite

Use of adefovir in the treatment of the chronic hepatitis B virus infection with resistance to lamivudine

By Barcena Marugan R.   Cid Gomez L.   Lopez Serrano P.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1841-1843

Elsevier

Access to resources Recommend Favorite

Resistance to Cytotoxic Chemotherapy Is Induced by NK Cells in Non-Hodgkin's Lymphoma Cells

By Cho Daeho   Kim Young-In   Kang Jae Seung   Hahm Eunsil   Yang Yoolhee   Kim Daejin   Kim Seonghan   Kim Yeong Seok   Hur Daeyoung   Park Hyunjeong   Hwang Young Il   Kim Tae-Sung   Lee Wang Jae  

Journal of Clinical Immunology, Vol. 24, Iss. 5, 2004-09 ,pp. : 553-560

Springer Publishing Company

Access to resources Recommend Favorite

Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases

By Kornacker M.   Kraemer A.   Leo E.   Ho A.  

Annals of Hematology, Vol. 81, Iss. 2, 2002-02 ,pp. : 103-105

Springer Publishing Company

Access to resources Recommend Favorite